Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination

The "canonical" proteasomal degradation signal is a substrate-anchored polyubiquitin chain. However, a handful of proteins were shown to be targeted following monoubiquitination. In this study, we established-in both human and yeast cells-a systematic approach for the identification of monoubiquitination-dependent proteasomal substrates. The cellular wild-type polymerizable ubiquitin was replaced with ubiquitin that cannot form chains. Using proteomic analysis, we screened for substrates that are nevertheless degraded under these conditions compared with those that are stabilized, and therefore require polyubiquitination for their degradation. For randomly sampled representative substrates, we confirmed that their cellular stability is in agreement with our screening prediction. Importantly, the two groups display unique features: monoubiquitinated substrates are smaller than the polyubiquitinated ones, are enriched in specific pathways, and, in humans, are structurally less disordered. We suggest that monoubiquitination-dependent degradation is more widespread than assumed previously, and plays key roles in various cellular processes

JDP2 overexpression provokes cardiac dysfunction in mice

The transcriptional regulator JDP2 (Jun dimerization protein 2) has been identified as a prognostic marker for patients to develop heart failure after myocardial infarction. We now performed in vivo studies on JDP2-overexpressing mice, to clarify the impact of JDP2 on heart failure progression. Therefore, during birth up to the age of 4 weeks cardiac-specific JDP2 overexpression was prevented by doxycycline feeding in transgenic mice. Then, JDP2 overexpression was started. Already after 1 week, cardiac function, determined by echocardiography, decreased which was also resembled on the cardiomyocyte level. After 5 weeks blood pressure declined, ejection fraction and cardiac output was reduced and left ventricular dilatation developed. Heart weight/body weight, and mRNA expression of ANP, inflammatory marker genes, collagen and fibronectin increased. Collagen 1 protein expression increased, and fibrosis developed. As an additional sign of elevated extracellular matrix remodeling, matrix metalloproteinase 2 activity increased in JDP2 mice. Thus, JDP2 overexpression is deleterious to heart function in vivo. It can be concluded that JDP2 overexpression provokes cardiac dysfunction in adult mice that is accompanied by hypertrophy and fibrosis. Thus, induction of JDP2 is a maladaptive response contributing to heart failure development

The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3

JDP2 is a ubiquitously expressed bZIP repressor protein. JDP2 binds TPA response element and cyclic AMP response element located within various promoters. JDP2 displays a high degree of homology to the immediate early gene ATF3. ATF3 plays a crucial role in the cellular adaptive response to multiple stress insults as well as growth stimuli. We have identified ATF3 as a potential target gene for JDP2 repression. JDP2 regulates the ATF3 promoter potentially through binding to both the consensus ATF/CRE site and a non-consensus ATF3 auto-repression DNA-binding element. Expression of ATF3 protein in wild-type mouse embryo fibroblast (MEF) cells is below the detectable levels, whereas, JDP2 disrupted MEF cells display noticeable level of ATF3 protein. Following either serum or ER stress stimulation, ATF3 expression is potentiated in JDP2-KO fibroblast cells as compared with wild-type cells. Mice with either JDP2 over-expression or JDP2 disruption display undetectable level of ATF3 protein. However, ATF3 induction in response to either growth or stress signals is dependent on JDP2 expression level. ATF3 induction is attenuated in JDP2 over-expressing mice whereas is potentiated in JDP2-KO mice as compared with the corresponding wild-type mice. Collectively, the data presented strongly suggest that JDP2 plays a role in the determination of the ATF3 adaptive cellular threshold response to different stress insults and growth stimuli

A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability

The production of cardiomyocytes from human induced pluripotent stem cells (hiPSC) holds great promise for patient-specific cardiotoxicity drug testing, disease modeling, and cardiac regeneration. However, existing protocols for the differentiation of hiPSC to the cardiac lineage are inefficient and highly variable. We describe a highly efficient system for differentiation of human embryonic stem cells (hESC) and hiPSC to the cardiac lineage. This system eliminated the variability in cardiac differentiation capacity of a variety of human pluripotent stem cells (hPSC), including hiPSC generated from CD34(+) cord blood using non-viral, non-integrating methods.We systematically and rigorously optimized >45 experimental variables to develop a universal cardiac differentiation system that produced contracting human embryoid bodies (hEB) with an improved efficiency of 94.7±2.4% in an accelerated nine days from four hESC and seven hiPSC lines tested, including hiPSC derived from neonatal CD34(+) cord blood and adult fibroblasts using non-integrating episomal plasmids. This cost-effective differentiation method employed forced aggregation hEB formation in a chemically defined medium, along with staged exposure to physiological (5%) oxygen, and optimized concentrations of mesodermal morphogens BMP4 and FGF2, polyvinyl alcohol, serum, and insulin. The contracting hEB derived using these methods were composed of high percentages (64-89%) of cardiac troponin I(+) cells that displayed ultrastructural properties of functional cardiomyocytes and uniform electrophysiological profiles responsive to cardioactive drugs.This efficient and cost-effective universal system for cardiac differentiation of hiPSC allows a potentially unlimited production of functional cardiomyocytes suitable for application to hPSC-based drug development, cardiac disease modeling, and the future generation of clinically-safe nonviral human cardiac cells for regenerative medicine

Endogenous Wnt/β-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem Cells

Wnt/beta-catenin signaling is an important regulator of differentiation and morphogenesis that can also control stem cell fates. Our group has developed an efficient protocol to generate cardiomyocytes from human embryonic stem (ES) cells via induction with activin A and BMP4.We tested the hypothesis that Wnt/beta-catenin signals control both early mesoderm induction and later cardiac differentiation in this system. Addition of exogenous Wnt3a at the time of induction enhanced cardiac differentiation, while early inhibition of endogenous Wnt/beta-catenin signaling with Dkk1 inhibited cardiac differentiation, as indicated by quantitative RT-PCR analysis for beta-myosin heavy chain (beta-MHC), cardiac troponin T (cTnT), Nkx2.5, and flow cytometry analysis for sarcomeric myosin heavy chain (sMHC). Conversely, late antagonism of endogenously produced Wnts enhanced cardiogenesis, indicating a biphasic role for the pathway in human cardiac differentiation. Using quantitative RT-PCR, we show that canonical Wnt ligand expression is induced by activin A/BMP4 treatment, and the extent of early Wnt ligand expression can predict the subsequent efficiency of cardiogenesis. Measurement of Brachyury expression showed that addition of Wnt3a enhances mesoderm induction, whereas blockade of endogenously produced Wnts markedly inhibits mesoderm formation. Finally, we show that Wnt/beta-catenin signaling is required for Smad1 activation by BMP4.Our data indicate that induction of mesoderm and subsequent cardiac differentiation from human ES cells requires fine-tuned cross talk between activin A/BMP4 and Wnt/beta-catenin pathways. Controlling these pathways permits efficient generation of cardiomyocytes for basic studies or cardiac repair applications

Apelin Enhances Directed Cardiac Differentiation of Mouse and Human Embryonic Stem Cells

Apelin is a peptide ligand for an orphan G-protein coupled receptor (APJ receptor) and serves as a critical gradient for migration of mesodermal cells fated to contribute to the myocardial lineage. The present study was designed to establish a robust cardiac differentiation protocol, specifically, to evaluate the effect of apelin on directed differentiation of mouse and human embryonic stem cells (mESCs and hESCs) into cardiac lineage. Different concentrations of apelin (50, 100, 500 nM) were evaluated to determine its differentiation potential. The optimized dose of apelin was then combined with mesodermal differentiation factors, including BMP-4, activin-A, and bFGF, in a developmentally specific temporal sequence to examine the synergistic effects on cardiac differentiation. Cellular, molecular, and physiologic characteristics of the apelin-induced contractile embryoid bodies (EBs) were analyzed. It was found that 100 nM apelin resulted in highest percentage of contractile EB for mESCs while 500 nM had the highest effects on hESCs. Functionally, the contractile frequency of mESCs-derived EBs (mEBs) responded appropriately to increasing concentration of isoprenaline and diltiazem. Positive phenotype of cardiac specific markers was confirmed in the apelin-treated groups. The protocol, consisting of apelin and mesodermal differentiation factors, induced contractility in significantly higher percentage of hESC-derived EBs (hEBs), up-regulated cardiac-specific genes and cell surface markers, and increased the contractile force. In conclusion, we have demonstrated that the treatment of apelin enhanced cardiac differentiation of mouse and human ESCs and exhibited synergistic effects with mesodermal differentiation factors

Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells

Human induced pluripotent stem cells (hiPSCs) possess the capabilities of self-renewal and differentiation into multiple cell types, and they are free of the ethical problems associated with human embryonic stem cells (hESCs). These characteristics make hiPSCs a promising choice for future regenerative medicine research. There are significant obstacles, however, preventing the clinical use of hiPSCs. One of the most obvious safety issues is the presence of residual undifferentiated cells that have tumorigenic potential. To locate residual undifferentiated cells, in vivo teratoma formation assays have been performed with immunodeficient animals, which is both costly and time-consuming. Here, we examined three in vitro assay methods to detect undifferentiated cells (designated an in vitro tumorigenicity assay): soft agar colony formation assay, flow cytometry assay and quantitative real-time polymerase chain reaction assay (qRT-PCR). Although the soft agar colony formation assay was unable to detect hiPSCs even in the presence of a ROCK inhibitor that permits survival of dissociated hiPSCs/hESCs, the flow cytometry assay using anti-TRA-1-60 antibody detected 0.1% undifferentiated hiPSCs that were spiked in primary retinal pigment epithelial (RPE) cells. Moreover, qRT-PCR with a specific probe and primers was found to detect a trace amount of Lin28 mRNA, which is equivalent to that present in a mixture of a single hiPSC and 5.0×104 RPE cells. Our findings provide highly sensitive and quantitative in vitro assays essential for facilitating safety profiling of hiPSC-derived products for future regenerative medicine research

Deployment of mating disruption dispensers before and after first seasonal male flights for the control of Aonidiella aurantii in citrus

The rejection of citrus fruit caused by infestations of the California red scale (CRS), Aonidiella aurantii (Maskell) (Hemiptera: Diaspididae), raises concerns about its management. This fact has led to the introduction of new integrated control methods in citrus orchards, including the implementation of techniques based on pheromones. Previous works described efficient mating disruption pheromone dispensers to control A. aurantii in the Mediterranean region. The main aims of the present study were to adjust the timing of dispenser applications and study the importance of controlling the early first generation of A. aurantii by testing two different application dates: before and after the first CRS male flight. The efficacy of the different mating disruption strategies was tested during 2010 in an experimental orchard and these results were confirmed during 2011 in a commercial citrus farm. Results showed that every mating disruption strategy achieved significantly lower male captures in monitoring pheromone traps compared with untreated plots, as well as mean fruit infestation reductions of about 80 %. The control of the first CRS generation is not essential for achieving a good efficacy as demonstrated in two locations with different pest pressure. The late application of MD dispensers before the second CRS male flight has proven to be effective, suggesting a new advantageous way to apply mating disruption.The authors want to thank Fernando Alfaro from Denia, Antonio Caballero, and Javier Macias from Rio Tinto Fruit S.A. (Huelva, Spain) for field support. We also thank Ecologia y Proteccion Agricola SL for the pheromone supply. This work has been funded by the Spanish Ministry of Science and Innovation (project AGL2009-10725) and Agroalimed Foundation. The translation of this paper was funded by the Universidad Politecnica de Valencia (Spain).Vacas González, S.; Alfaro Cañamás, C.; Primo Millo, J.; Navarro-Llopis, V. (2015). Deployment of mating disruption dispensers before and after first seasonal male flights for the control of Aonidiella aurantii in citrus. Journal of Pest Science. 88(2):321-329. https://doi.org/10.1007/s10340-014-0623-1S321329882Avidov Z, Balshin M, Gerson U (1970) Studies on Aphytis coheni, a parasite of the California red scale, Aonidiella aurantii in Israel. Biocontrol 15:191–207Barzakay I, Hefetz A, Sternlicht M, Peleg BA, Gokkes M, Singer G, Geffen D, Kronenberg S (1986) Further field trials on management of the California red scale, Aonidiella aurantii, by mating disruption with its sex-pheromone. Phytoparasitica 14:160–161Bedford ECG (1996) Problems which we face in bringing red scale, Aonidiella aurantii (Maskell), under biological control in citrus in South Africa. Proc Int Soc Citriculture 1:485–492Campos-Rivela JM, Martínez-Ferrer MT, Fibla-Queralt JM (2012) Population dynamics and seasonal trend of California red scale (Aonidiella aurantii Maskell) in citrus in Northern Spain. Span J Agric Res 10:198–208Collins PJ, Lambkin TM, Bodnaruk P (1994) Suspected resistance to methidation in Aonidiella aurantii (Maskell) (Homoptera: diaspididae) from Queensland. J Aust Entomol Soc 33:325–326Corma A, Muñoz-Pallares J, Primo-Yufera E (1999) Production of semiochemical emitters having a controlled emission speed which are based on inorganic molecular sieves. World Patent WO9944420Corma A, Muñoz-Pallares J, Primo-Yufera E (2000) Emitter of semiochemical substances supported on a sepiolite, preparation process and applications. World Patent WO0002448DeBach P (1959) New species and strains of Aphytis (Hymenoptera: Eulophidae) parasitic on the California red scale, Aonidiella aurantii (Mask.), in the Orient. Ann Entomol Soc Am 52:354–362DeBach P, Argyriou L (1967) The colonization and success in Greece of some imported Aphytis spp. (Hymenoptera: Aphelinidae) parasitic on citrus scale insects (Homoptera: Diaspididae). Biocontrol 12:325–342Desneux N, Decourtye A, Delpuech JM (2007) The sublethal effects of pesticides on beneficial arthropods. Ann Rev Entomol 52:81–106Diari Oficial de la Comunitat Valenciana (DOCV) (2008) DOCV no. 5901, 26. Resolution 27 October 2008 of Consellería de Agricultura, Pesca y Alimentación; November 2008. http://www.docv.gva.es/datos/2008/11/26/pdf/2008_13692.pdfDomínguez-Ruiz J, Sanchis J, Navarro-Llopis V, Primo J (2008) A new long-life trimedlure dispenser for Mediterranean fruit fly. J Econ Entomol 101:1325–1330Eliahu M, Blumberg D, Horowitz AR, Ishaaya I (2007) Effect of pyriproxyfen on developing stages and embryogenesis of California red scale (CRS), Aonidiella aurantii. Pest Manag Sci 63:743–746Furness G, Buchanan G, George R, Richardson N (1983) A history of the biological and integrated control of red scale, Aonidiella aurantii on citrus in the lower Murray Valley of Australia. Biocontrol 28:99–212Grafton-Cardwell EE, Gu P (2003) Conserving vedalia beetle, Rodolia cardinalis (Mulsant) (Coleoptera : Coccinellidae), in citrus: a continuing challenge as new insecticides gain registration. J Econ Entomol 96:1388–1398Grafton-Cardwell EE, Reagan CA (1995) Selective use of insecticides for control of armored scale (Homoptera: Diaspididae) in San-Joaquin Valley California citrus. J Econ Entomol 88:1717–1725Grafton-Cardwell EE, Vehrs SLC (1995) Monitoring for organophosphate-resistant and carbamate-resistant armored scale (Homoptera: Diaspididae) in San-Joaquin Valley citrus. J Econ Entomol 88:495–504Grafton-Cardwell EE, Lee JE, Stewart JR, Olsen KD (2006) Role of two insect growth regulators in integrated pest management of citrus scales. J Econ Entomol 99:733–744Grout TG, Richards GI (1991a) Effect of buprofezin applications at different phenological times on California red scale (Homoptera: Diaspididae). J Econ Entomol 84:1802–1805Grout TG, Richards GI (1991b) Value of pheromone traps for predicting infestations of red scale, Aonidiella aurantii (Maskell) (Homoptera: Diaspididae), limited by natural enemy activity and insecticides used to control citrus thrips, Scirtothrips aurantii Faure (Thysanoptera: Thripidae). J Appl Entomol 111:20–27Grout TG, Du Toit WJ, Hofmeyr JH, Richards GI (1989) California red scale (Homoptera: Diaspididae) phenology on citrus in South Africa. J Econ Entomol 82:793–798Hefetz A, Kronengerg S, Peleg BA, Bar-zakay I (1988) Mating disruption of the California red scale Aonidiella aurantii (Homoptera: Diaspididae). In: Proceeding 6th International Citrus Congress, Tel Aviv (Israel), pp 1121–1127Hernández-Penadés P, Rodríguez-Reina JM, García-Marí F (2002) Umbrales de tratamiento para cóccidos diaspídidos en cítricos. Bol San Veg Plagas 28:469–478Hothorn T, Bretz F, Westfall P (2008) Simultaneous Inference in General Parametric Models. Biometrical J 50:346–363Ioratti C, Anfora G, Tasin M, De Cristofaro A, Witzgall P, Lucchi A (2011) Chemical ecology and management of Lobesia botrana (Lepidoptera: Tortricidae). J Econ Entomol 104:1125–1137Kehat M, Anshelevich L, Harel M, Dunkelblum E (1995) Control of the codling moth (Cydia pomonella) in apple and pear orchards in Israel by mating disruption. Phytoparasitica 23:285–296Kennett CE, Hoffmann RW (1985) Seasonal development of the California red scale (Homoptera: Diaspididae) in San Joaquin Valley citrus based on degree-day accumulation. J Econ Entomol 78:73–79Levitin E, Cohen E (1998) The involvement of acetylcholinesterase in resistance of the California red scale shape Aonidiella aurantii to organophosphorus pesticides. Entomol Exp Appl 88:115–121Lykouressis D, Perdikis D, Samartzis D, Fantinou A, Toutouzas S (2005) Management of the pink bollworm Pectinophora gossypiella (Saunders) (Lepidoptera: Gelechiidae) by mating disruption in cotton fields. Crop Prot 24:177–183McLaren IW, Buchanan GA (1973) Parasitism by Aphytis chrysomphali Mercet and A. melinus Debach of Californian red scale, Aonidiella aurantii (Maskell), in relation to seasonal availability of suitable stages of the scale. Austr J Zool 21:111–117Moreno DS, Kennett CE (1985) Predictive year-end California red scale (Homoptera: Diaspididae) orange fruit infestations based on catches of males in the San-Joaquin Valley. J Econ Entomol 78:1–9Moreno DS, Luck RF (1992) Augmentative releases of Aphytis melinus (Hymenoptera: Aphelinidae) to suppress California red scale (Homoptera: Diaspididae) in southern California lemon orchards. J Econ Entomol 85:1112–1119Pekas A, Aguilar A, Tena A, García-Marí F (2010) Influence of host size on parasitism by Aphytis chrysomphali and A. melinus (Hymenoptera: Aphelinidae) in Mediterranean populations of California red scale Aonidiella aurantii (Hemiptera: Diaspididae). Biol Control 55:132–140Rill S, Grafton-Cardwell EE, Morse JG (2007) Effects of pyriproxyfen on California red scale (Hemiptera: Diaspididae) development and reproduction. J Econ Entomol 100:1435–1443Rodrigo E, Troncho P, García-Marí F (1996) Parasitoids (Hymenoptera: Aphelinidae) of three scale insects (Homoptera: Diaspididae) in a citrus grove in Valencia, Spain. Entomophaga 41:77–94Roelofs WL, Gieselmann MJ, Cardé AM, Tashiro H, Moreno DS, Henrick CA, Anderson RJ (1977) Sex-pheromone of California red scale, Aonidiella aurantii. Nature 26:698–699Rongai D, Cerato C, Lazzeri L, Palmieri S, Patalano G (2008) Vegetable oil formulation as biopesticide to control California red scale (Aonidiella aurantii Maskell). J Pest Sci 81:179–185Sorribas JJ, Rodríguez R, Rodrigo E, García-Marí F (2008) Niveles de parasitismo y especies de parasitoides del piojo rojo de california Aonidiella aurantii (Hemiptera: Diaspididae) en cítricos de la Comunidad Valenciana. Bol San Veg Plagas 34:201–210Sorribas J, van Baaren J, Garcia-Marí F (2012) Effects of climate on the introduction, distribution and biotic potential of parasitoids: applications to biological control of California red scale. Biol Control 62:103–112Staten RT, Flint HM, Weddle RC, Quintero E, Zarate RE, Finell CM, Hernandes M, Yamamoto A (1987) Pink bollworm (Lepidoptera: Gelechiidae): large-scale field trials with a high-rate gossyplure formulation. J Econ Entomol 80:1267–1271Tashiro H, Chambers DL (1967) Reproduction in the California Red Scale, Aonidiella aurantii (Homoptera: Diaspididae). I. Discovery and extraction of a female sex pheromone. Ann Entomol Soc Am 60:1166–1170Tena A, Llácer E, Urbaneja A (2013) Biological control of a non-honeydew producer mediated by a distinct hierarchy of honeydew quality. Biol Control 67:117–122University of California (1991) Integrated pest management for citrus. University of California, BerkeleyVacas S, Alfaro C, Navarro-Llopis V, Primo J (2009) The first account of the mating disruption technique for the control of California red scale Aonidiella aurantii Maskell (Homoptera: Diaspididae) using new biodegradable dispensers. Bull Entomol Res 99:415–423Vacas S, Alfaro C, Navarro-Llopis V, Primo J (2010) Mating disruption of California red scale, Aonidiella aurantii Maskell (Homoptera: Diaspididae), using biodegradable mesoporous pheromone dispensers. Pest Manag Sci 66:745–751Vacas S, Vanaclocha P, Alfaro C, Primo J, Verdú MJ, Urbaneja A, Navarro-Llopis V (2011) Mating disruption for the control of Aonidiella aurantii Maskell (Hemiptera: Diaspididae) may contribute to increased effectiveness of natural enemies. Pest Manag Sci 68:142–148Vanaclocha P, Vacas S, Alfaro C, Primo J, Verdú MJ, Navarro-Llopis V, Urbaneja A (2012) Life history parameters and scale-cover surface area of Aonidiella aurantii are altered in a mating disruption environment: implications for biological control. Pest Manag Sci 68:1092–1097Vanaclocha P, Vidal-Quist C, Oheix S, Montón H, Planes L, Catalán J, Tena A, Verdú MJ, Urbaneja A (2013) Acute toxicity in laboratory tests of fresh and aged residues of pesticides used in citrus on the parasitoid Aphytis melinus. J Pest Sci 86:329–336Yarom I, Blumberg D, Ishaaya I (1988) Effects of buprofezin on California red scale (Homoptera: Diaspididae) and Mediterranean black scale (Homoptera: Coccidae). J Econ Entomol 81:1581–1585Yust HR, Nelson HD, Busbey RL (1943) Comparative susceptibility of two strains of California red scale to HCN, with special reference to the inheritance of resistance. J Econ Entomol 36:744–74

Augmentation of Neovascularizaiton in Hindlimb Ischemia by Combined Transplantation of Human Embryonic Stem Cells-Derived Endothelial and Mural Cells

BACKGROUND: We demonstrated that mouse embryonic stem (ES) cells-derived vascular endothelial growth factor receptor-2 (VEGF-R2) positive cells could differentiate into both endothelial cells (EC) and mural cells (MC), and termed them as vascular progenitor cells (VPC). Recently, we have established a method to expand monkey and human ES cells-derived VPC with the proper differentiation stage in a large quantity. Here we investigated the therapeutic potential of human VPC-derived EC and MC for vascular regeneration. METHODS AND RESULTS: After the expansion of human VPC-derived vascular cells, we transplanted these cells to nude mice with hindlimb ischemia. The blood flow recovery and capillary density in ischemic hindlimbs were significantly improved in human VPC-derived EC-transplanted mice, compared to human peripheral and umbilical cord blood-derived endothelial progenitor cells (pEPC and uEPC) transplanted mice. The combined transplantation of human VPC-derived EC and MC synergistically improved blood flow of ischemic hindlimbs remarkably, compared to the single cell transplantations. Transplanted VPC-derived vascular cells were effectively incorporated into host circulating vessels as EC and MC to maintain long-term vascular integrity. CONCLUSIONS: Our findings suggest that the combined transplantation of human ES cells-derived EC and MC can be used as a new promising strategy for therapeutic vascular regeneration in patients with tissue ischemia

Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes

Transplantation of human embryonic stem cell-derived cardiomyocytes (hESC-CM) for cardiac regeneration is hampered by the formation of fibrotic tissue around the grafts, preventing electrophysiological coupling. Investigating this process, we found that: (1) beating hESC-CM in vitro are embedded in collagens, laminin and fibronectin, which they bind via appropriate integrins; (2) after transplantation into the mouse heart, hESC-CM continue to secrete collagen IV, XVIII and fibronectin; (3) integrin expression on hESC-CM largely matches the matrix type they encounter or secrete in vivo; (4) co-transplantation of hESC-derived endothelial cells and/or cardiac progenitors with hESC-CM results in the formation of functional capillaries; and (5) transplanted hESC-CM survive and mature in vivo for at least 24 weeks. These results form the basis of future developments aiming to reduce the adverse fibrotic reaction that currently complicates cell-based therapies for cardiac disease, and to provide an additional clue towards successful engraftment of cardiomyocytes by co-transplanting endothelial cells